About Sepragen
Sepragen is a Healthcare company based in Hayward (United States) founded in 1987. Biomolecular separation technologies are enabled for bioprocessing applications. Sepragen has raised $5 million across 3 funding rounds from investors including National Science Foundation. The company has 19 employees. Sepragen offers products and services including QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its legal entity is SEPRAGEN CORPORATION. Its competitors include ChromaTan, Sepax Technologies and Semba Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Sepragen Corporation was founded in 1987 and is headquartered in Hayward, United States. Operations focus on the biotechnology sector, where products such as bioreactors, chromatography systems, resins, and columns are developed and manufactured. These enable large-scale separation and production of biotech drugs, nutritional products, and beverages. Radial flow chromatography columns are utilized, along with automated buffer dilution systems and disposable benchtop chromatography systems.
- Headquarters Hayward, United States
- Employees 19
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sepragen.com
- Social LinkedIn Facebook
- Legal Name Sepragen Corporation
- Total Equity Funding$5M (USD)
in 3 rounds
- Latest Funding Round$5M (USD), Series A
Sep 2024
- Investors
- Employee Count19
Products & Services of Sepragen
Sepragen offers a comprehensive portfolio of products and services, including QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins.
Automated multi-use systems for cGMP purification in bioprocessing
Radial flow columns for high-throughput biological separations
Process-scale resins for efficient molecule separation in manufacturing
Funding Insights of Sepragen
Sepragen has successfully raised a total of $5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 3
- Last Round Series A — $5M
- First Round $250,000
(Jul 2013)
- Investors Count 1
All 3 funding rounds of Sepragen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $5M | Series A | – | – | – |
| Jun 2017 | $224,999 | Grant | – | – | |
| Jul 2013 | $250,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Sepragen
Sepragen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Sepragen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sepragen
10 people are tracked at Sepragen (4 in leadership, 1 in board & advisors, 5 in team); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Vinit Saxena | Chairman, CEO & CTO | Leadership |
Renu Chabra | Director & VP, Manufacturing & Engineering | Leadership |
Salah Ahmed | Director of Quality & Tech Support | Leadership |
Henry N. Edmunds | Acting CFO & Director | Leadership |
George Martinez | Advisor | Board & advisors |
Sergey Novoseltsev | Service Engineer in Industrial Downstream Chromatography in Biotechnology | Team |
Michael Sr. | Senior Quality Engineer | Team |
Robyn Burrows-Ownbey | Mechanical Engineer | Team |
Jorge Picazo Ruiz Esparza | Senior Controls Engineer | Team |
Ankit Agrawal | Mechanical Design Engineer | Team |
Complete people profiles for Sepragen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sepragen
3 dated milestones of Sepragen across 37 years, from founding to its latest funding, stage changes and deals.
- Founded Sepragen is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series A, of $5.0M.
Competitors of Sepragen
Sepragen has 3 listed competitors in our database, 3 of them funded. They include ChromaTan, Sepax Technologies and Semba Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | Continuous countercurrent tangential chromatography separation technology is developed. | ||
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| sembabio.com | 2005 | Madison, United States | $5.85M | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) |
Detailed competitors of Sepragen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sepragen
The website of Sepragen (sepragen.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 29.1% vs previous month
Websites whose visitors overlap most with Sepragen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Sepragen (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sepragen
Complete news archive for Sepragen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sepragen
Sepragen was founded in 1987 and raised its 1st funding round 26 years after it was founded.
Sepragen is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Sepragen is a funded company, having raised a total of $5M across 3 funding rounds to date. The company's 1st funding round was a Grant of $250K, raised on Jul 2013.
Sepragen has 19 employees.
Sepragen Corporation was founded in 1987 and is headquartered in Hayward, United States. Operations focus on the biotechnology sector, where products such as bioreactors, chromatography systems, resins, and columns are developed and manufactured. These enable large-scale separation and production of biotech drugs, nutritional products, and beverages. Radial flow chromatography columns are utilized, along with automated buffer dilution systems and disposable benchtop chromatography systems.
Sepragen's top competitors include ChromaTan, Sepax Technologies and Semba Biosciences.
Sepragen offers QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins.
Sepragen has 1 investor. Key investors include National Science Foundation.
Sepragen operates through Sepragen Corporation.